INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 46m ago
HOUSE PTR6m ago
SEC 13F6m ago
ROBINHOOD CHAIN6m ago
LC
Corporate insider

Lowry Simon C

SVP, R&D, CMOCIK 0002044279

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score21
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
LC
Lowry Simon CSVP, R&D, CMO
EBSEmergent BioSolutions Inc.
Grant or award
A—
100.1K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Emergent BioSolutions Inc.SVP, R&D, CMO · Dec 16, 2025
17
LC
Lowry Simon CSVP, R&D, CMO
EBSEmergent BioSolutions Inc.
Grant or award
A
—
44.8K sh
Mar 3, 2026
Mar 5, 2026
traded Mar 3, 2026
+2d
SEC FORM 4

Evidence

16
LC
Lowry Simon CSVP, R&D, CMO
EBSEmergent BioSolutions Inc.
Tax withholding
F$90K
10.6K sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC FORM 4

Evidence

9
LC
Lowry Simon CSVP, R&D, CMO
EBSEmergent BioSolutions Inc.
Tax withholding
F$40K
3,543 sh
Dec 14, 2025Dec 16, 2025
traded Dec 14, 2025
+2dSEC FORM 4

Evidence